Serum Galectin-3 as a Marker of Human Papillomavirus Infection

Status Completed

Clinical Trial Summary

This study aimed to assess the serum Galectin-3 levels in patients with warts both before and after cryotherapy and to investigate its potential contribution to the pathogenesis of human papillomavirus infection.

Clinical Trial Description

Galectin-3 regulates many functions at the cellular level such as cell attachment, proliferation, and apoptosis. Numerous viral illnesses, including human papillomavirus infection, were reported to have elevated serum levels of Galectin-3. . Methods: Fifty patients suffering from warts, and fifty healthy controls were included in this study. Enzyme-linked immunosorbent assay was used to measure serum levels of Galectin-3 both before and 2 weeks after the last cryotherapy session. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT06005389
Study type	Observational
Source	Assiut University
Contact
Status	Completed
Phase
Start date	December 1, 2021
Completion date	February 1, 2023

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT05458869` - Evaluating the Human Papillomavirus Self-Collection Experience in Individuals Who Have Experienced Sexual Trauma
Completed	`NCT01932697` - Radiation Therapy and Docetaxel in Treating Patients With HPV-Related Oropharyngeal Cancer	Phase 2
Completed	`NCT03265743` - HPV Vaccination in Women With Cystic Fibrosis	N/A
Completed	`NCT00543543` - Broad Spectrum HPV (Human Papillomavirus) Vaccine Study in 16-to 26-Year-Old Women (V503-001)	Phase 3
Recruiting	`NCT04226313` - Self-sampling for Non-attenders to Cervical Cancer Screening	N/A
Completed	`NCT06199128` - Efficacy and Safety of Carboxymethyl Beta-glucan and Policarbophil in HPV Positive Patients
Active, not recruiting	`NCT01824537` - Transmission Reduction and Prevention With HPV Vaccination (TRAP-HPV) Study	Phase 4
Terminated	`NCT01082861` - Efficacy and Immunomodulation Study of Simultaneous Human Papillomavirus/ Hepatitis B (HPV/HBV) Vaccination	Phase 4
Unknown status	`NCT01087164` - Brief Interventions to Increase HPV Vaccine Acceptance in School-based Health Centers	N/A
Completed	`NCT01265212` - Prevalence of Human Papillomavirus in Men Living in the Northern Plains	N/A
Completed	`NCT00572832` - Randomized Trial of Alternative Quadrivalent Human Papilloma Virus (HPV) Vaccination Schedules in a University Setting	N/A
Completed	`NCT03158220` - Immunogenicity and Tolerability of Broad Spectrum Human Papillomavirus (HPV) Vaccine in Adult and Young Adult Women (V503-004)	Phase 3
Recruiting	`NCT05210348` - Clinical Evaluation of Detection of High Risk HPV in Urine
Completed	`NCT05680454` - A Phase I Trial Evaluate the Safety and Tolerability Profile of HPV Vaccine	Phase 1
Completed	`NCT04133610` - HPVPro Study: Comparison of HPV Detection in Clinician-collected Cervical Swabs and Self-sampled Cervicovaginal Swabs	N/A
Completed	`NCT00988884` - A Study of V503 Given Concomitantly With Menactra™ and Adacel™ in 11 to 15 Year Olds (V503-005)	Phase 3
Not yet recruiting	`NCT05981807` - HPV Infection, Sexually Transmitted Infections and Anal Dysplasia in the Transgender Population
Recruiting	`NCT03302858` - A Safety and Efficacy Trial of Circumferential Anal Canal Radiofrequency Ablation for High-Grade Anal Intraepithelial Neoplasia Using the BARRX™ Anorectal Wand	Phase 2
Completed	`NCT01694875` - Clinical Evaluation of the APTIMA® HPV 16 18/45 Genotype Assay on the PANTHER® System	N/A
Completed	`NCT01205412` - An Observational Study on the Prevalence of Human Papillomavirus Types in Women in the Kingdom of Bahrain	N/A